🌟 New Discoveries in Colon Cancer Treatment with a New Immunotherapy Combination: What Does the New Study Say? 🌟
📢 Published on June 13, 2024 Researchers from Stanford University have published the results of a study in Nature Medicine that examined the effectiveness of the treatment combining Botensilimab and…
⭐ Roni: “I feel like my life has been saved in the last hour we’ve been talking, unbelievable.” ⭐
👉Fate can change in an instant. For Roni, 54 years old, a father and husband, that moment came when he reached out to us. Roni was diagnosed with salivary gland…
🏥 When Professionalism and Humanity Meet: How We Helped Michal ❤️
We want to share with you the touching story of Michal (a pseudonym), a 32-year-old incredible woman battling metastatic breast cancer, who we have been supporting for some time. Our…
🌟 **Which is Better for Cancer Patients: Investigational Drugs or Standard Drugs?** 🌟
📢 ** Published on April 30, 2024** Researchers from McGill University in Montreal conducted a comprehensive study involving 128 clinical trials. In this study, there were two groups of patients:…
Colorectal Cancer – Krazati with or without Erbitux in Mutated KRAS G12C
Background Adagrasib, also called “Krazati”, is a tablet taken by mouth which inhibits KRAS G12C mutation. It has shown clinical activity in pretreated patients with several tumor types, including colorectal…
Cannabidiol oil failed to overcome palliative care in advanced cancer
Background The use of cannabis for therapeutic benefit has risen exponentially over the past few years with strong public belief in its benefit. This is despite very limited evidence of…
Gastric Cancer – Zolbetuximab Prolongs Survival
About Locally Advanced Unresectable Metastatic Gastric Cancer and Gastroesophageal Junction Cancer (GEJ) Gastric cancer is the fifth most diagnosed cancer worldwide. Signs and symptoms can include indigestion or heartburn; pain…
Sarcoma – Lenvima Plus Halaven in Advanced Disease
In Short This phase Ib/II study evaluated the efficacy and safety of Lenvima combined with Halaven in the treatment of patients with advanced leiomyosarcoma and liposarcoma. The results showed that…
Glioblastoma – Radiotherapy Plus Temodar With Nimotuzumab
Background about Glioblastoma and the new drug Glioblastoma (GBM) has a poor prognosis, and patients with Epidermal Growth Factor Receptor (EGFR) amplification have an even worse prognosis. Nimotuzumab is an…